세계 요실금용 기기 시장 규모는 2023년 29억 7,000만 달러, 2030년까지 43억 달러에 달할 것으로 예상되며, 2024-2030년의 예측 기간 동안 연평균 6.36% 성장할 전망입니다. 요실금 유병률 증가, 혁신적인 기기 개발, 요로 감염과 같은 비뇨기과 질환에 취약한 노인 인구, 골반저의 약화, 임신, 당뇨병, 폐경기, 파킨슨병과 같은 질병으로 인해 요실금용 기기 시장이 성장할 것으로 예상됩니다.
요실금용 기기 시장 역학
요실금용 기기 시장은 요실금 유병률 증가로 인해 크게 증가하고 있으며, National Association for Continence(2018)에 따르면 미국인 3,300만 명 이상이 요실금이나 방광 질환을 앓고 있다고 합니다. 전 세계적으로 요실금에 대한 부담이 증가함에 따라 요실금용 기기 시장이 크게 성장하고 있습니다.
또한, 요실금 관련 첨단 기기 개발은 빠른 속도로 발전하고 있습니다. 예를 들어, 2020년 2월 Atlantic Therapeutics는 미국 FDA가 스트레스성 요실금(SUI)을 위한 비침습적 장치이자 임상적으로 입증된 방광 약화의 근본 원인을 치료하는 웨어러블 장치인 INNOVO®에 대한 일반의약품(OTC) 허가를 승인했다고 발표했습니다. INNOVO®는 현재까지 미국에서 처방전 없이 구입할 수 있으며, 전 세계적으로 350만 건 이상의 안전하고 성공적인 치료가 이루어졌습니다고 밝혔습니다. 이러한 요실금용 기기 분야의 기술 발전은 전 세계 요실금용 기기 시장을 견인할 가능성이 높습니다.
또한, 노년층은 요로 감염이나 골반저의 약화와 같은 비뇨기과 질환이 발생하기 전에 요실금이 발생하기 쉬우며, Urology Centers of Alabama(2018)에 따르면 과민성 방광(OAB)은 누구에게나 발생할 수 있지만, 가장 많이 발생하는 연령대는 40세 이후이며, 특히 여성에서 가장 많이 발생합니다. 40세 이상의 여성 3명 중 1명이 요실금 증상을 경험하고, 전 세계 60세 이상 여성 2명 중 1명이 요실금 증상을 경험하며, 80세 이상 여성은 요실금 증상이 없는 경우가 더 드물다고 합니다. 드뭅니다. 따라서 노인 인구가 증가함에 따라 비뇨기과 질환의 유병률이 증가하여 요실금 시장의 성장을 가속할 것으로 예상됩니다.
COVID-19의 유행은 전 세계에 큰 영향을 미치고 있습니다. 이 전염병으로 인해 외래 진료가 취소되고, 긴급하지 않은 병원 및 시술이 중단되었습니다. 그 결과 비뇨기과 진료 및 관련 시술에 대한 정기적인 임상 검사가 감소했습니다. 이에 따라 수술을 통해 요실금용 기기를 받기 위해 기다리는 환자가 시간이 지남에 따라 증가했습니다. 따라서 요실금용 기기에 대한 수요는 예측 기간 동안 가속화되어 시장 성장을 가속하는 요인으로 작용하고 있습니다.
그러나 요실금 및 수술 후 합병증에 대한 환자의 낮은 인식과 같은 특정 요인이 세계 요실금용 기기 시장의 성장을 억제할 것으로 예상됩니다.
요실금용 기기 시장 부문별 분석
요실금용 기기 시장의 제품 부문에서 요도 슬링 시장 부문은 전 세계 요실금용 기기 시장에서 큰 점유율을 차지할 것으로 예상됩니다. 이 제품 부문의 큰 시장 점유율은 빠른 구호를 위해 이러한 장치를 채택하는 환자가 증가하고 있기 때문입니다. 또한 요도 슬링은 첨단 장치이며 시장에서 사용 가능한 모든 기존 장치를 대체하고 있습니다.
또한, 이 슬링은 환자에게서 채취한 인대, 조직, 힘줄 등 다양한 재료로 구성되며, 플라스틱과 같은 합성 재료로 제조할 수도 있습니다.
여성의 요실금 유병률이 증가함에 따라 요도 슬링 수술에 대한 수요도 증가하고 있습니다. 또한, 요실금 분야에서 수행되고 있는 중요한 연구 활동은 결과적으로 시장을 촉진할 것으로 예상됩니다.
또한, 환자들 사이에서 기존 기기에서 첨단 기기로의 전환이 일어나고 있습니다. 이는 요실금용 기기에 대한 환자의 수용성을 높입니다. 따라서 위의 모든 요인이 요실금용 기기 시장의 성장을 가속할 것으로 예상됩니다.
이 보고서는 세계 요실금용 기기 시장에 대해 조사 분석했으며, 시장 규모와 예측, 촉진요인 및 과제, 기업 및 제품 프로파일 등을 전해드립니다.
Urinary Incontinence Devices Market By Product (Urinary Catheters, Urethral Slings, Electrical Stimulation Devices, Artificial Urinary Sphincters, Others), By Type (External Devices, Internal Devices), By Patient Type (Male, Female), By End-User (Hospitals And Clinics, Ambulatory Surgery Centers, Others), By Geography is expected to grow at a steady CAGR forecast till 2030 owing to the development of innovative devices and and surge in urological conditions.
Global Urinary Incontinence Devices Market was valued at USD 2.97 billion in 2023, growing at a CAGR of 6.36% during the forecast period from 2024 to 2030, to reach USD 4.30 billion by 2030. The Urinary Incontinence Devices market is expected to witness growth due to the rising prevalence of urinary incontinence cases, development of innovative devices, aging population prone to urological conditions like urinary tract infections, weakening of pelvic floor, and conditions including pregnancy, diabetes, menopause, and Parkinson's disease.
Urinary Incontinence Devices Market Dynamics:
Urinary Incontinence Devices Market has significantly increased due to the rising prevalence of urinary incontinence cases. As per the National Association for Continence 2018, over 33 million Americans suffer from some type of urinary incontinence or bladder condition. Owing to the growing burden of urinary incontinence across the globe, the Urinary Incontinence Devices market has been rising significantly.
In addition, the development of urinary incontinence advanced devices is thriving at a great pace. For instance, in February 2020, Atlantic Therapeutics announced that the US FDA granted over-the-counter (OTC) clearance to INNOVO®, a non-invasive device for non-invasive device for stress urinary incontinence (SUI), clinically proven, and wearable device that treats the root cause of bladder weakness. INNOVO® was previously available in the US by prescription, with more than 3.5 million safe and successful therapy sessions delivered worldwide. Such technological advancement in the field of Urinary Incontinence Devices is likely to boost the Global Urinary Incontinence Devices Market.
Also, the aging population is more prone to urinary incontinence, by the time urological conditions like urinary tract infections and weakening of pelvic floor develop. According to the Urology Centers of Alabama 2018, although overactive bladders (OAB) can happen to anyone, the most common ages are post-40 for men and, especially, women. According to the CentraState Healthcare System, 2019, over the age of 40, one in three women experience symptoms of urinary incontinence, while it affects one in two women over age 60 globally. For women age 80 and older, it's rare not to have some type of incontinence. Therefore, as the aging population increases, there will be more prevalence of urological conditions, which will eventually boost the growth of the Urinary Incontinence market.
The outbreak of the COVID-19 pandemic had a profound impact across the globe. The pandemic led to the cancellation of outpatient visits and the suspension of non-emergency hospitals and procedures. This resulted in the reduced number of routine clinical examinations of the urological visits and related procedures. Thus, the number of patients waiting to get urinary incontinence devices through surgery increased over time. Therefore, the demand for Urinary Incontinence Devices has accelerated over the forecast period which will drive the market growth.
However, certain factors like less awareness among the patient population regarding incontinence and post-operative complications are expected to restrict the growth of the Global Urinary Incontinence Devices Market.
Urinary Incontinence Devices Market Segment Analysis:
Urinary Incontinence Devices Market by Product (Urinary Catheters, Urethral Slings, Electrical Stimulation Devices, Artificial Urinary Sphincters, Others), by Type (External Devices, Internal Devices), by Patient Type (Male, Female), by End-User (Hospitals and Clinics, Ambulatory Surgery Centers, Others), and by Geography (North America, Europe, Asia-Pacific, and Rest of the World).
Urinary Incontinence Devices market product segment, the Urethral Slings market segment will hold the major share of the Global Urinary Incontinence Devices market. The large market share of this product segment can be attributed to the growing patient adoption for these devices due to quick relief. Moreover, Urethral Slings are more advanced devices and have replaced all the conventional devices available in the market.
Furthermore, these slings are made up of different materials like ligament, tissue, tendons taken from the patient or they can also be manufactured from synthetic sources like plastic.
The rising prevalence of urinary incontinence among the women population is also increasing the demand for urethral sling surgery. Moreover, the significant research activities taking place in the Urinary Incontinence arena will eventually boost the market.
Additionally, a shift in trend from conventional devices to advanced devices can be seen among the patient population. This will increase the acceptance of Urinary Incontinence Devices for patients. Hence, all the above-mentioned factors are expected to drive the segment growth of the Urinary Incontinence Devices market.
North America Is Expected To Dominate The Overall Global Urinary Incontinence Devices Market:
North America is expected to dominate the overall Urinary Incontinence Devices market during the forecast period. This domination is due to the rising prevalence of urinary incontinence cases and urological conditions among men and women in the region. As per Urology Care Foundation 2022, a quarter to a third of men and women in the US suffer from urinary incontinence. About 33 million have overactive bladder representing symptoms of urgency, frequency, and urge incontinence.
According to the same statistics, as many as 30% of men and 40% of women in the United States live with OAB symptoms. Thus, the burgeoning cases of the diseases will contribute to the growth of the Urinary Incontinence Devices Market in the region as the demand will increase.
Further, in North America and at the global level the United States represents the largest market worldwide supported by the development of advanced devices and easy regulatory initiatives by the government. One such technological advancement is the development of implantable tibial neuromodulation (TNM) device designed to provide relief from symptoms of bladder incontinence, developed by Medtronic PLC. The device received approval from US FDA to proceed with an investigational device exemption (IDE) trial in April 2022.
Europe and Asia-Pacific region have the future potential growth for the Global Urinary Incontinence Devices market. This is owing to the rising burden of urological diseases and COVID-19 pandemic in the European region countries and Asian countries. Rising product launch and commercialization agreements among the key manufacturers and other companies are anticipated to boost the Urinary Incontinence Devices market. For instance, in April 2022, in Australia, Analytica Ltd. signed a joint venture agreement with Hebei Nacol Bio-Technology Co. Ltd. and Shijiazhuang Biosphere Pty Ltd., of Hebei Province, China, to manufacture and distribute its Pericoach device for urinary incontinence in China, Macau, Hong Kong, and Taiwan. Such initiatives are anticipated to boost the Urinary Incontinence Devices Market.
Urinary Incontinence Devices Market Key Players:
Some of the key market players operating in the Global Urinary Incontinence Devices Market include NeoTract, Inc., Cook Medical Inc., C.R. Bard Inc., Coloplast Corporation, Boston Scientific Corporation, Ethicon US, LLC, Medtronic PLC, A.M.I. Ltd., Teleflex Incorporated, Hollister Incorporated, ConvaTec Group PLC, Caldera Medical Inc., Prosurg, Inc., Laborie, Inc., Becton, Dickinson and Company, ZSI Surgical Implants, Atlantic Therapeutics, B. Braun Melsungen AG, Flexicare (Group) Limited, InControl Medical among others.
Recent Developmental Activities in the Urinary Incontinence Devices Market:
In September 2022, at American Urological Association Annual Meeting, a novel, ultra-miniaturized sacral nerve modulation (SNM) system was shown to be both efficacious and safe in treating patients with urge urinary incontinence (UUI), according to findings from the feasibility phase of the SANS-UUI study.
In May 2022, the University of Washington School of Medicine developed and tested 3 new devices to relieve symptoms of urinary incontinence. The first device tested in a clinical trial was a neuromodulation device. The second device involves an electrode about the size of a small pill and is implanted through a needle in the lower back alongside one of the main pelvic nerves. The third device is a soft, rubber ring with embedded electrodes placed in the vagina like a pessary or diaphragm.
Key Takeaways from the Urinary Incontinence Devices Market Report Study
Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)
The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Urinary Incontinence Devices market.
Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
Key companies dominating the Global Urinary Incontinence Devices Market.
Various opportunities are available for the other competitor in the Urinary Incontinence Devices Market space.
What are the top-performing segments in 2023? How these segments will perform in 2030?
Which are the top-performing regions and countries in the current market scenario?
Which are the regions and countries where companies should have concentrated on opportunities for Urinary Incontinence Devices market growth in the coming future?
Target Audience who can be benefited from this Urinary Incontinence Devices Market Report Study
Urinary Incontinence Devices providers
Research organizations and consulting companies
Urinary Incontinence Devices related organization, association, forum, and other alliances
Government and corporate offices
Start-up companies, venture capitalists, and private equity firms
Distributors and Traders in Urinary Incontinence Devices
Various End-users want to know more about the Urinary Incontinence Devices Market and the latest technological developments in the Urinary Incontinence Devices market.
Frequently Asked Questions for Urinary Incontinence Devices Market:
Urinary Incontinence Devices are medical devices that help in collecting and holding urine. Urinary Incontinence (UI) is a medical disorder in which a person unconsciously urinates. It is differentiated into four types namely, stress urinary incontinence, urge urinary incontinence, overflow urinary incontinence, and functional urinary incontinence.
Global Urinary Incontinence Devices Market was valued at USD 2.97 billion in 2023, growing at a CAGR of 6.36% during the forecast period from 2024 to 2030, to reach USD 4.30 billion by 2030.
The major drivers driving the demand for Urinary Incontinence Devices are the rising prevalence of urinary incontinence cases, the development of innovative devices, the aging population prone to urological conditions like urinary tract infections, weakening of pelvic floor, and conditions including pregnancy, diabetes, menopause, and Parkinson's disease.
Some of the key market players operating in the Urinary Incontinence Devices market include NeoTract, Inc., Cook Medical Inc., C.R. Bard Inc., Coloplast Corporation, Boston Scientific Corporation, Ethicon US, LLC, Medtronic PLC, A.M.I. Ltd., Teleflex Incorporated, Hollister Incorporated, ConvaTec Group PLC, Caldera Medical Inc., Prosurg, Inc., Laborie, Inc., Becton, Dickinson and Company, ZSI Surgical Implants, Atlantic Therapeutics, B. Braun Melsungen AG, Flexicare (Group) Limited, InControl Medical, and others.
North America is expected to dominate the overall global Urinary Incontinence Devices market during the forecast period from 2024 to 2030. This domination is due to the rising prevalence of urinary incontinence cases and urological conditions among men and women in the region.